IFNG and hematocrit: LCP2, PTPRC, and eight other genes were identified as hub genes that may affect HT origin and development, and four pathways (IL-6/JAK/STAT3 pathway, IFN-α signaling, IFN-γ signaling, and inflammatory response) were identified to be potential key pathways in HT.